Marcin Feder

1 Patent

• US124158112025

  1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione Compounds as Therapeutic Agents Activating TP53

  ADAMED PHARMA S.A.

  0 cites